Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Oxygen targets in comatose survivors of cardiac arrest

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Blood-pressure targets in comatose survivors of cardiac arrest

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Monkeypox Virus Infection in Humans across 16 Countries - April-June 2022

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Frostbite - Diagnosis and Therapy

    Publikation: Bidrag til tidsskriftKommentar/debatForskningpeer review

  4. Overall Survival with Brentuximab Vedotin in Stage III or IV Hodgkin's Lymphoma

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. Restriction of Intravenous Fluid in ICU Patients with Septic Shock

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Does childhood exposure to biodiverse greenspace reduce the risk of developing asthma?

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Association between inflammatory markers and survival in comatose, resuscitated out-of-hospital cardiac arrest patients

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Long-term effects of cardiac rehabilitation after heart valve surgery - results from the randomised CopenHeartVR trial

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

BACKGROUND: The appropriate oxygenation target for mechanical ventilation in comatose survivors of out-of-hospital cardiac arrest is unknown.

METHODS: In this randomized trial with a 2-by-2 factorial design, we randomly assigned comatose adults with out-of-hospital cardiac arrest in a 1:1 ratio to either a restrictive oxygen target of a partial pressure of arterial oxygen (Pao2) of 9 to 10 kPa (68 to 75 mm Hg) or a liberal oxygen target of a Pao2 of 13 to 14 kPa (98 to 105 mm Hg); patients were also assigned to one of two blood-pressure targets (reported separately). The primary outcome was a composite of death from any cause or hospital discharge with severe disability or coma (Cerebral Performance Category [CPC] of 3 or 4; categories range from 1 to 5, with higher values indicating more severe disability), whichever occurred first within 90 days after randomization. Secondary outcomes were neuron-specific enolase levels at 48 hours, death from any cause, the score on the Montreal Cognitive Assessment (ranging from 0 to 30, with higher scores indicating better cognitive ability), the score on the modified Rankin scale (ranging from 0 to 6, with higher scores indicating greater disability), and the CPC at 90 days.

RESULTS: A total of 789 patients underwent randomization. A primary-outcome event occurred in 126 of 394 patients (32.0%) in the restrictive-target group and in 134 of 395 patients (33.9%) in the liberal-target group (hazard ratio, 0.95; 95% confidence interval, 0.75 to 1.21; P = 0.69). At 90 days, death had occurred in 113 patients (28.7%) in the restrictive-target group and in 123 (31.1%) in the liberal-target group. On the CPC, the median category was 1 in the two groups; on the modified Rankin scale, the median score was 2 in the restrictive-target group and 1 in the liberal-target group; and on the Montreal Cognitive Assessment, the median score was 27 in the two groups. At 48 hours, the median neuron-specific enolase level was 17 μg per liter in the restrictive-target group and 18 μg per liter in the liberal-target group. The incidence of adverse events was similar in the two groups.

CONCLUSIONS: Targeting of a restrictive or liberal oxygenation strategy in comatose patients after resuscitation for cardiac arrest resulted in a similar incidence of death or severe disability or coma. (Funded by the Novo Nordisk Foundation; BOX ClinicalTrials.gov number, NCT03141099.).

OriginalsprogEngelsk
TidsskriftThe New England journal of medicine
Vol/bind387
Udgave nummer16
Sider (fra-til)1467-1476
Antal sider10
ISSN0028-4793
DOI
StatusUdgivet - 20 okt. 2022

Bibliografisk note

Copyright © 2022 Massachusetts Medical Society.

ID: 85792950